APDA Partners with Smart Patients to Support Parkinson’s Online Community
The American Parkinson Disease Association (APDA) is collaborating with Smart Patients — an online community connecting Parkinson’s patients and their families…
Articles by Ana de Barros, PhD
International Stem Cell’s Trial in Parkinson’s Can Continue, Board Says
International Stem Cell’s clinical trial testing its ISC-hpNSC neural cells for the treatment of Parkinson’s disease (PD) can move forward,…
Michael J. Fox Foundation Awards 3 Trial Centers $125,000 in New Parkinson’s Trial Recruitment Program
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is giving three clinical trial centers a $125,000 incentive to…
Phase 2b Trial Completed for Potential Disease-Modifying Parkinson’s Treatment
Living Cell Technologies (LCT) has completed treatment in the six patients enrolled in the third and final cohort of the…
BRAIN Center Aims to Develop Innovative Technologies to Help Those with Neurological Diseases
American scientists have formed what they call the BRAIN Center to develop, test and market innovative technologies to help people with…
Trial Data on Rytary and Off Episodes in Advanced Parkinson’s Being Given at AAN
Impax Laboratories is presenting data on its approved Parkinson’s disease treatment, Rytary, as well as findings in a clinical trial assessing…
Dancing Might Help Prevent Parkinson’s, Recent Research Points Out
Dancing helps prevent Parkinson’s disease, obesity, dementia, depression and anxiety, says Dr. Patricia Bragg, CEO of organic health company …
Adamas to Give Presentations on Treatment for Involuntary Muscle Movements in Parkinson’s
Adamas Pharmaceuticals will make two presentations in Boston this month on ADS-5102 as a treatment for involuntary muscle movements associated with…
MJFF Grant Will Support Mission Therapeutics’ Test of Novel USP30 Therapy in Parkinson’s Models
British pharmaceutical firm Mission Therapeutics will test its potent, selective USP30-targeted inhibitors in stem cell-derived Parkinson’s disease models, as part of research…
Zambon, Valeo Collaborate to Bring Xadago to Canadian Parkinson’s Patients
Italian pharmaceutical conglomerate Zambon has partnered with Montreal-based Valeo Pharma to bring Xadago (safinamide) to Canada, where 100,000 patients living with…